
MDNA
Healthcare · Biotechnology · $11.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2023 | After the close | -0.05 | -0.04 | +27.6% |
| Jul 28, 2023 | Before the open | -0.06 | -0.04 | +33.3% |
| Jun 27, 2023 | Before the open | -0.09 | -0.06 | +33.3% |
| Feb 7, 2023 | Before the open | -0.09 | -0.02 | +77.8% |
| Nov 4, 2022 | Before the open | -0.07 | -0.04 | +42.9% |
| Aug 15, 2022 | Before the open | -0.08 | -0.07 | +12.5% |
| Jun 22, 2022 | Before the open | -0.11 | -0.06 | +45.5% |
| Feb 9, 2022 | Before the open | -0.13 | -0.09 | +30.8% |
| Nov 12, 2021 | Before the open | -0.12 | -0.15 | -25.0% |
| Aug 13, 2021 | Before the open | -0.10 | -0.12 | -20.0% |
| May 28, 2021 | Before the open | -0.09 | -0.11 | -22.2% |
| Feb 12, 2021 | Before the open | -0.08 | -0.09 | -8.5% |
| Nov 13, 2020 | After the close | -0.06 |
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune…
| -0.06 |
| -8.2% |
| Aug 4, 2020 | Before the open | -0.04 | -0.04 | +5.5% |
| May 15, 2020 | Before the open | -0.04 | -0.05 | -24.3% |
| Feb 13, 2020 | Before the open | -0.07 | -0.07 | 0.0% |
| Nov 5, 2019 | Before the open | -0.07 | -0.07 | 0.0% |
| Aug 9, 2019 | Before the open | -0.08 | -0.05 | +37.5% |
| Jun 25, 2019 | Before the open | -0.11 | -0.03 | +72.7% |
| Feb 14, 2019 | After the close | — | -0.05 | — |
| Nov 13, 2018 | After the close | — | -0.03 | — |
| Aug 13, 2018 | Before the open | — | -0.03 | — |
| Jun 27, 2018 | After the close | -0.11 | -0.05 | +54.5% |
| Feb 12, 2018 | Before the open | -0.14 | -0.09 | +35.7% |